PHARMACYTE BIOTECH, INC. Contractual Obligation
PHARMACYTE BIOTECH, INC. (PMCB) had Contractual Obligation of $220.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Notes
us-gaap:ContractualObligation · last filed 2026-09-14
- 2026-07-31: Contractual Obligation $220.00K.
- 2026-04-30: Contractual Obligation $220.00K.
- 2026-01-31: Contractual Obligation $543.00K.
- 2025-10-31: Contractual Obligation $543.00K.
| Period end | Contractual Obligation |
|---|---|
| 2026-07-31 | $220.00K 10-Q · filed 2026-09-14 |
| 2026-04-30 | $220.00K 10-K · filed 2026-07-29 |
| 2026-01-31 | $543.00K 10-Q · filed 2026-03-17 |
| 2025-10-31 | $543.00K 10-Q · filed 2025-12-18 |
| 2025-07-31 | $591.00K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $591.00K 10-K · filed 2025-08-11 |
| 2017-04-30 | $0.00 10-Q · filed 2017-12-14 |
| 2017-01-31 | $0.00 10-Q · filed 2017-03-13 |
| 2016-10-31 | $0.00 10-Q · filed 2016-12-02 |
| 2016-07-31 | $0.00 10-Q · filed 2016-09-06 |
| 2016-04-30 | $150.00K 10-K · filed 2017-07-27 |
| 2016-01-31 | $300.00K 10-Q · filed 2016-03-08 |
| 2015-10-31 | $600.00K 10-Q/A · filed 2016-01-19 |
| 2015-07-31 | $700.00K 10-Q/A · filed 2016-01-19 |
| 2015-04-30 | $1.00M 10-K · filed 2016-07-29 |
| 2014-04-30 | $0.00 10-K/A · filed 2016-01-19 |
| 2013-10-31 | $400.00K 10-Q · filed 2013-12-16 |
| 2013-07-31 | $400.00K 10-Q · filed 2013-09-16 |
| 2013-04-30 | $400.00K 10-K · filed 2013-07-29 |
| 2013-01-31 | $400.00K 10-Q · filed 2013-03-26 |
| 2012-10-31 | $400.00K 10-Q · filed 2012-12-26 |
| 2012-07-31 | $400.00K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |